Bone Biologics Corp. (BBLG) vs Seelos Therapeutics, Inc. (SEELQ)

Bone Biologics Corp. and Seelos Therapeutics, Inc. are both Biotechnology companies. Bone Biologics Corp. is the larger, with a market value of $1.1M against $700.0K — 1.5× the size. Seelos Therapeutics, Inc. has the higher net margin (203.1% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 10 metrics below, Seelos Therapeutics, Inc. leads on 6 and Bone Biologics Corp. on 4.

Valuation

Metric BBLG SEELQ Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 0.18 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 0.50 9.21
Earnings yield (342.50%) 0.00% (33.15%)
Free cash flow yield (365.78%) 0.00% (25.50%)

Profitability

Metric BBLG SEELQ Biotechnology median
Gross margin — 100.00% 65.16%
Operating margin 0.00% (1,480.04%) 0.00%
Net margin 0.00% 203.13% 0.00%
Free cash flow margin 0.00% (659.09%) 0.00%
Return on equity (54.96%) (10.86%) (56.36%)
Return on assets (50.55%) 57.34% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BBLG SEELQ Biotechnology median
Revenue growth (TTM) — (51.45%) 6.02%
EPS growth (last fiscal year) 90.85% 62.72% 30.26%
Revenue growth, 5-year CAGR — (22.63%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BBLG SEELQ Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.67 0.08 4.72
Net debt to EBITDA 1.65 0.09 0.96

Dividend

Metric BBLG SEELQ Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BBLG SEELQ Biotechnology median
Market cap 1.07m 700.00k 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack